CoChat

Régulation du métabolisme énergétique par l’AMPK: Une nouvelle voie thérapeutique pour le traitement des maladies métaboliques et cardiaques

Open access
Foretz, Marc, Taleux, Nellie, Guigas, Bruno, Horman, Sandrine, Beauloye, Christophe, Andreelli, Fabrizio, Bertrand, Luc, Viollet, Benoît · 2006 · médecine/sciences
Cited by 56

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

The 5' AMP-activated protein kinase (AMPK) is a sensor of cellular energy homeostasis well conserved in all eukaryotic cells. AMPK is activated by rising AMP and falling ATP, either by inhibiting ATP production or by accelerating ATP consumption, by a complex mechanism that results in an ultrasensitive response. AMPK is a heterotrimeric enzyme complex consisting of a catalytic subunit alpha and two regulatory subunits beta and gamma. AMP activates the system by binding to the gamma subunit that triggers phosphorylation of the catalytic alpha subunit by the upstream kinases LKB1 and CaMKKbeta. Once activated, it switches on catabolic pathways (such as fatty acid oxidation and glycolysis) and switches off ATP-consuming pathways (such as lipogenesis) both by short-term effect on phosphorylation of regulatory proteins and by long-term effect on gene expression. Dominant mutations in the regulatory gamma subunit isoforms cause hypertrophy of cardiac and skeletal muscle providing a link in human diseases caused by defects in energy metabolism. As well as acting at the level of the individual cell, the system also regulates food intake and energy expenditure at the whole body level, in particular by mediating the effects of adipokines such as leptin and adiponectin. Moreover, the AMPK system is one of the probable target for the anti-diabetic drug metformin and rosiglitazone. The relationship between AMPK activation and beneficial metabolic effects provides the rationale for the development of new therapeutic strategies. Thus, pharmacological AMPK activation may, through signaling, metabolic and gene expression effects, reduce the risk of Type 2 diabetes, metabolic syndrome and cardiac diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1051/medsci/2006224381

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 56

Metadata

Authors
Foretz, M., Taleux, N., Guigas, B., Horman, S., Beauloye, C., Andreelli, F., Bertrand, L., & Viollet, B.
Venue
médecine/sciences
Publisher
EDP Sciences
Published
2006-04
Volume
22
Issue
4
Pages
381-388
ISSN
  • 0767-0974 (ISSN-L)
  • 1958-5381
OpenAlex
W1720064984
Cited by
56
References
18
FWCI
0.98
Type
journal article
Language
fr
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Régulation du métabolisme énergétique par l’AMPK: Une nouvelle voie thérapeutique pour le traitement des maladies métaboliques et cardiaques. https://app.cochat.ai/papers/10.1051/medsci/2006224381
The paper
Foretz, M., Taleux, N., Guigas, B., Horman, S., Beauloye, C., Andreelli, F., Bertrand, L., & Viollet, B. (2006). Régulation du métabolisme énergétique par l’AMPK: Une nouvelle voie thérapeutique pour le traitement des maladies métaboliques et cardiaques. médecine/sciences. https://doi.org/10.1051/medsci/2006224381

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.